A comprehensive view of Gracell Biotechnologies Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca completes acquisition of Gracell Biotechnologies, bolstering its pipeline of cell therapies designed to combat cancer and autoimmune diseases; the deal is worth approximately US$1.2B
Published: February 23, 2024 by AstraZeneca AB
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases; the acquisition includes GC012F, a potential new treatment for multiple myeloma, other hematologic malignancies and autoimmune diseases
Published: December 26, 2023 by AstraZeneca AB

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count